These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6431032)

  • 1. [Chemotherapy of leptospirosis--effects of tobramycin, dibekacin and amikacin on the Leptospira].
    Kobayashi Y; Oyama T; Ninomiya T
    Kansenshogaku Zasshi; 1984 Mar; 58(3):197-202. PubMed ID: 6431032
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dibekacin--a novel aminoglycoside antibioticl. Antimicrobial activity and parallel resistance in vitro].
    Schassan HH; Witt U
    Arzneimittelforschung; 1979; 29(2):174-8. PubMed ID: 582126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-year survey of amikacin use and aminoglycoside resistance in a general hospital in Belgium.
    Vanhoof R; Hubrechts JM; Nyssen HJ; Roebben E
    Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):183-5. PubMed ID: 3134209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New aminoglycoside antibiotics].
    Dzierzanowska D
    Pol Tyg Lek; 1977 Sep; 32(38):1483-6. PubMed ID: 905200
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative study of in vitro antimicrobial activity and human pharmacokinetics of dibekacin and tobramycin.
    Verbist L; Tjandramaga TB; Mullie A; Van Hecken A; Verbesselt R; De Schepper PJ
    Acta Clin Belg; 1982; 37(3):148-57. PubMed ID: 7124274
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
    Reynaud AE; Coude du Foresto B; Derriennic M; Courtieu AL
    Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates.
    Price KE; DeFuria MD; Pursiano TA
    J Infect Dis; 1976 Nov; 134 SUPPL():S249-61. PubMed ID: 62814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefoxitin: synergism with aminoglycosides in vitro.
    Une T; Osada Y; Ogawa H
    Arzneimittelforschung; 1981; 31(5):761-4. PubMed ID: 6791664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative in vitro activity of dibekacin, gentamicin and tobramycin on 617 bacterial strains].
    Coulet M; Brun Y; Forey F; Fleurette J
    Nouv Presse Med; 1982 Nov; 11(46):3391-5. PubMed ID: 7155846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amikacin.
    Gleckman R
    Am Fam Physician; 1976 Dec; 14(6):75. PubMed ID: 998471
    [No Abstract]   [Full Text] [Related]  

  • 11. Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.
    Noone P
    Drugs; 1984 Jun; 27(6):548-78. PubMed ID: 6376062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the antibacterial activity of amikacin (BB-K8) with other aminoglycosides against pathogens recently isolated from clinical materials (author's transl) ].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1975 Aug; 28(4):530-7. PubMed ID: 240047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid development of resistance of gentamicin, tobramycin and amikacin by E. coli 07.
    Humble MW; Bettelheim KA
    N Z Med J; 1978 May; 87(612):366. PubMed ID: 353599
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical pharmacology of the most frequently used aminoglucosides: gentamycin, tobramycin and amikacin].
    Cuena Boy R; Azanza Perea JR; Echeverría Echepare LM; Honorato Pérez J
    Rev Med Univ Navarra; 1983 Dec; 27(4):21-7. PubMed ID: 6676898
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of the resistance mechanisms of gentamicin-resistant Gram-negative bacilli and their susceptibility to tobramycin, netilmicin and amikacin.
    Maes P
    J Antimicrob Chemother; 1985 Mar; 15(3):283-9. PubMed ID: 3997704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuromuscular blocking properties of tobramycin, dibekacin and ribostamycin in man (author's transl)].
    Arai T; Hashimoto Y; Shima T; Matsukawa S; Iwatsuki KI
    Jpn J Antibiot; 1977 Apr; 30(4):281-4. PubMed ID: 864858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gentamicin-resistant gram-negative bacilli in hospital patients. Part II. In vitro aspects including susceptibility to tobramycin and amikacin.
    Block CS; Fabian B; Robinson RG
    S Afr Med J; 1978 Mar; 53(11):396-99. PubMed ID: 675374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibacterial activity of gentamicin, tobramycin, amikacin, and sisomicin in vitro (author's transl)].
    Skalova R; Hajsig D; Babić I; Mostovac D
    Lijec Vjesn; 1978 Nov; 100(11):708-10. PubMed ID: 107386
    [No Abstract]   [Full Text] [Related]  

  • 19. Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria.
    Moellering RC; Wennersten C; Kunz LJ; Poitras JW
    Am J Med; 1977 Jun; 62(6):873-81. PubMed ID: 868901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of an aminoglycoside resistance plasmid by Serratia marcescens during treatment of meningitis with amikacin.
    Rubens CE; McGee ZA; Farrar WE
    J Infect Dis; 1980 Mar; 141(3):346-50. PubMed ID: 6988523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.